| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5503113 | Journal of the Neurological Sciences | 2016 | 5 Pages |
Abstract
We report a lower than expected number of cancer cases in MS patients compared to the general population. MS patients with a personal history of cancer were more likely to report DMT use suggesting that DMTs may abrogate the lower incidence of cancer in MS.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Deeya MD, Katelyn S. MS, Barbara MPH, PhD, Caila B. MPH, Diane PhD, Theresa PhD, Bianca MD, on behalf of the New York State Multiple Sclerosis Consortium on behalf of the New York State Multiple Sclerosis Consortium,